ArticleFrontiers in pharmacology2018

A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells.

Patricia Martín-Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.